Mark E. Bernard
Papers
1
Total Citations
12
H-Index
1
About
Mark E. Bernard is a radiation oncologist whose research focuses on the optimization of stereotactic radiosurgery (SRS) for brain metastases, particularly in non-small cell lung cancer (NSCLC). His most-cited work, a 2011 study on the effect of treatment time on outcomes in NSCLC brain metastases treated with SRS, has garnered 12 citations and helped illuminate how procedural timing influences patient prognosis. Bernard’s contributions lie in refining SRS protocols to improve local control and survival, addressing critical gaps in the management of intracranial disease. His research underscores the importance of balancing treatment efficiency with clinical efficacy, offering practical insights for radiation oncology practice. While his citation count reflects a focused, early-career impact, Bernard’s work is notable for its clinical relevance, directly informing treatment decisions for one of the most common cancer types. His findings contribute to a growing body of evidence that aims to personalize radiosurgery, making him a valuable voice in the ongoing effort to enhance outcomes for patients with brain metastases.
Research Focus
Key Achievements
Top Papers
- 1